TPG and Par Pharmaceutical have announced the completion of Par's purchase by certain TPG affiliates. According to the merger agreement, Par's stockholders are eligible to earn $50.00 in cash, without interest, less any applicable ...
Teva, a provider of generic pharmaceutical drugs, has introduced Rivastigmine capsules for generic prescription. Rivastigmine is generic equivalent to Novartis' Exelon capsules. Rivastigmine is indicated for use in the symptomatic ...
Tags: Teva, rivastigmine, Novartis'Exelon capsules
Pernix Therapeutics has entered into a definitive agreement to acquire Cypress Pharmaceuticals and Hawthorn Pharmaceuticals in Madison, Mississippi, US. Hawthorn offers branded drugs including allergy, respiratory, iron deficiency, ...
Tags: Pernix Therapeutics, Cypress Pharmaceuticals, Hawthorn Pharmaceuticals
Packaging company in the US, MeadWestvaco’s (MWV) medication adherence solution Shellpak Renew has bagged the Best Sustainable Pharmaceutical Packaging award at the CPhI Worldwide event in Madrid, Spain. The Shellpak Renew, launched ...
Tags: Pharmaceutical Packaging, environmentally-friendly format, spine labels
Avery Dennison has launched a new anti-counterfeiting technology Sharp Tear that provides an extra layer of product security for pharmaceutical brands and enables existing serial numbers to be read directly through the label. According to ...
Tags: Avery Dennison, product security, pharmaceutical brands
These are days of opportunity for metal thieves—and California is the Wild West of illegal metal trading.An aspiring young degenerate with a little nerve and a fast truck can turn a quick dollar at pop-up scrap yards that feed Asia's ...
Regeneca has issued a voluntary nationwide recall of RegenArouse, lot number 130100, as it contains a drug not listed on the label. Tadalafil is an FDA-approved drug used as treatment for male erectile dysfunction (ED). The ...
Tags: recall of RegenArouse, drug industry, FDA
Regeneca has issued a voluntary recall of all lots of single capsule packet RegenErect, labeled as a dietary supplement. RegenErect is a blue capsule sold individually in foil packets with a UPC code of 816860010055. The company ...
Tags: Recall, RegenErect, medical product, drug industry
Branham Law Group, a US law firm, is investigating Pfizer for its recall of 14 lots of Lo/Ovral-28 tablet packs and 14 lots of generic Norgestrel and Ethinyl Estradiol tablets. Pfizer manufactured both drugs and they were marketed in ...
Tags: Investigation, recalls, medical industry
Berkley Life Sciences has rolled out a new insurance product, which attempts to hold pharmaceutical and medical device companies liable due to shortage in supply of their drugs, devices or other life science products or components. The ...
Tags: Berkley Life Sciences, insurance product, harmaceutical, medical device
Stiefel, a GSK company, has acquired the development and commercialization rights to Welichem Biotech (WBI) anti-inflammatory agent, WBI-1001. The acquisition follows the previously announced asset purchase agreement. WBI-1001 ...
Tags: acquisition, clinical drugs, Stiefel
Saladax Biomedical has signed a distribution contract with INyDIA Labs for My5-FU, a test that measures levels of 5-fluorouracil (5-FU), in the blood of cancer patients, in Spain and Protugal. INyDIA will provide My5-FU test kits to ...
Tags: medical research, medical test, clinical research, company collaboration
Astellas Pharma and Japan's National Institute of Advanced Industrial Science and Technology (AIST) have entered into a research partnership for the discovery and development of drugs targeting neglected tropical diseases caused by ...
Tags: Astellas Pharma, AIST, FE drug
Akrimax Pharmaceuticals has introduced Suprenza (phentermine HCl) orally disintegrating tablets (ODT) for the management of exogenous obesity. The company has launched Suprenza ODT in 15mg and 30mg dosage strengths. Suprenza is ...
Tags: pharceumatical product, obesity drugs, clinical research
AmDerma Pharmaceuticals and Oculus Innovative Sciences have signed a multi-country agreement to develop and commercialize Microcyn technology drug compounds for major dermatological conditions. The agreement includes licensing of the ...
Tags: Microcyn technology drug compounds, dermatology compounds